# IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation

> **NCT03700385** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 40 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** IOWA Approach Endocardial Ablation System

## Key facts

- **NCT ID:** NCT03700385
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-19
- **Primary completion:** 2018-12-21
- **Final completion:** 2020-01-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03700385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03700385, "IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03700385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*